|Publication number||USRE39635 E1|
|Application number||US 10/085,261|
|Publication date||May 15, 2007|
|Filing date||Feb 28, 2002|
|Priority date||Sep 30, 1998|
|Also published as||CA2283984A1, CN1251850A, DE69904131D1, DE69904131T2, EP0990668A1, EP0990668B1, US6031059|
|Publication number||085261, 10085261, US RE39635 E1, US RE39635E1, US-E1-RE39635, USRE39635 E1, USRE39635E1|
|Inventors||Douglas G. Vanderlaan, Frank Molock, Giancarlo Fruzzetti|
|Original Assignee||Vanderlaan Douglas G, Frank Molock, Giancarlo Fruzzetti|
|Export Citation||BiBTeX, EndNote, RefMan|
|Patent Citations (20), Referenced by (20), Classifications (13), Legal Events (2)|
|External Links: USPTO, USPTO Assignment, Espacenet|
This application is a Reissue of U.S. appln. No. 09/163,693, now issued as U.S. Pat. No. 6,031,059.
The invention relates to hydrogels for use in the production of biomedical devices. In particular, the invention provides hydrogels formed from siloxane prepolymers and a hydrophilic monomer, which hydrogels are optically transparent.
The use of hydrogels for the manufacture of biomedical devices is known. Hydrogels that are copolymers of siloxane prepolymers and hydrophilic monomers offer certain advantages in comparison with conventional hydrogels. However, it is difficult to produce optically transparent, homogeneous hydrogels from these prepolymers and monomers making the use of the hydrogels limited.
Known methods for making homogeneous hydrogels from siloxane prepolymers include using diluents to compatabilize the siloxane with the hydrophilic monomer and using siloxanes into which hydrophilic groups are incorporated. However, the use of diluents is disadvantageous because of their volatility and their use may result in polymers of inferior quality. Incorporation of hydrophilic groups is disadvantageous in that it requires the use of complicated syntheses and the resulting polymer may not be optically transparent. Therefore, a need exists for a method of polymerizing siloxane prepolymers and hydrophilic monomers that overcome these disadvantages.
It is a discovery of the invention that homogeneous, optically transparent hydrogels can be formed from the polymerization of siloxane prepolymers and/or monomers with a hydrophilic monomer without incorporation of hydrophilic groups into the siloxane and with a reduction in the amount of diluents needed or, in some cases, without the use of diluents. The hydrogels of the invention are useful in the manufacture of biomedical devices, meaning devices designed to be used while in or on either or both human tissue or fluid. Examples of such devices include, without limitation, stents, implants, catheters, and ophthalmic lenses. In a preferred embodiment, the biomedical device is an ophthalmic lens including, without limitation, contact or intraocular lenses. More preferably, the device is a contact lens.
In one embodiment, the invention provides a process for producing hydrogels comprising, consisting essentially of, and consisting of the steps of a.) polymerizing a hydrophobic siloxane prepolymer, a silylated hydrophilic monomer, and optionally a hydrophobic siloxane monomer to form a polymer; and b.) hydrolyzing the polymer. In another embodiment, the invention provides a hydrogel comprising, consisting essentially of, and consisting of a hydrophobic siloxane prepolymer, a silylated hydrophilic monomer, and optionally a hydrophobic siloxane monomer.
By “hydrophobic siloxane prepolymer” and “hydrophobic siloxane monomer” is meant a siloxane prepolymer or siloxane monomer, respectively, that does not have an amount of hydrophilic groups, such as a hydroxyl group, incorporated into the main chain or a side chain to allow for blends to be made of it with a hydrophilic monomer absent the use of high levels of diluent. Suitable hydrophobic siloxane prepolymers are of the formula:
wherein R1 is hydrogen or an alkyl of 1 to 5 carbon atoms, R2 is an alkyl of 1 to 5 carbon atoms, n=1 to 12, and z=1 to 500. Preferably, the prepolymer is a macromer, such as:
wherein n and m are each independently 0 to 500 and (n+m)=10 to 500, R4, R6, R7, R8, and R9 are each independently a monovalent alkyl of 1 to 5 carbon atoms, or aryl group that may be further substituted with alcohol, ester, amine, ketone, carboxylic acid, or ether groups, and R3, R5, and R10 are each independently a monovalent alkyl or 1 to 5 carbon atoms or aryl group that may be further substituted with alcohol, ester, amine, ketone, carboxylic acid or ether groups or have the structure:
providing that at least one of R3, R5, and R10 are according to this structure wherein R11 is a divalent alkyl group of 1 to 5 carbon atoms, R12 and R13 are independently H, a monovalent alkyl of 1 to 5 carbon atoms or aryl group that may be further substituted with an alcohol, ester, amine, ketone, carboxylic acid or ether group, or have the structure:
wherein R16 is H or a monovalent polymerizable group containing acryloyl, methacryloyl, styryl, vinyl, allyl, or N-vinyl lactam; R18 is H, a monovalent alkyl of 1 to 5 carbon atoms or aryl group that can be further substituted with alcohol, ester, amine, ketone, carboxylic acid, or ether groups, or a polymerizable group containing acrylate, methacrylate, styryl, vinyl, allyl or N-vinyl lactam; R14, R15, and R16 are independently H, or a monovalent alkyl of 1 to 5 carbon atoms or aryl that can be further substituted with alcohol, ester, amine, ketone, carboxylic acid or ether groups, or R14 and R17, or R17 and R15 can be bonded to form a ring structure, providing that at least one of the Structure B groups on the monomer contains polymerizable groups. Preparation of such macromers is known in the art.
Preferred hydrophobic prepolymers are α,ω-bismethacryloxypropyl macromers. More preferred is α,ω-bismethacryloxypropyl polydimethylsiloxane. Other hydrophilic prepolymers that can be used include linear or branched polymers or copolymers made from hydrophobic monomers such as 3-methacryloxypropyltris (trimethylsiloxy)silane, said prepolymers having polymerizable functional groups such as methacrylate or styryl. Preparation of such prepolymers is described in U.S. Pat. Nos. 5,010,141; 5,057,578; 5,314,960; 5,371,147 and 5,336,797 incorporated in their entireties herein by reference.
In the process of the invention, the prepolymer may be used alone or in combination with a hydrophobic siloxane monomer. Hydrophobic siloxane monomers useful in the invention are of the formula:
wherein R19 and R20 are each independently hydrogen or methyl, R21, R22, and R23 are each independently a monovalent alkyl of 1 to 5 carbon atoms or aryl, j=1 to 10 and k=0 to 3. Examples of useful siloxane monomers include, without limitation, polysiloxyanylalkyl(meth)acrylates, preferably, 3-methacryloxypropyltris(trimethylsiloxy)silane or 3-methacryloxypropylbis(trimethylsiloxy)methylsilane. Hydrophobic siloxane monomers useful in the invention are commercially available or may be synthesized through known methods.
In the process of the invention, the siloxane prepolymer alone, or in combination with the siloxane monomer, is polymerized with a silylated hydrophilic monomer. Any known hydrophilic monomer capable of being silylated may be used. Preferably, the silylated monomer used is of the formula:
wherein R24 is hydrogen or methyl, R25 is hydrogen or methyl, and R26 is a monoalkyl, preferably methyl. More preferably, the silylated monomer is a polyalkylsilyl ether of a hydroxyalkyl(meth)acrylamide or a polyalkylsilyl ether of a hydroxyl styrene or of a hydroxy alkyl styrene. Most preferably, the silylated monomer is 2-hydroxymethacrylamide trimethylsilyl ether.
The silylated monomer may be prepared by silylating the hydroxyl groups of a hydrophilic monomer by any known method. For example, the hydroxyl groups may be reacted with a silylating agent such as a trialkylsilyl halogenide, hexamethyldisilizane, trimethylsilyldiethylamine, or the like. Solvents and catalysts useful in the silylation, as well as reaction conditions, are well known in the art.
The siloxane prepolymer, alone or in combination with a siloxane monomer, are polymerized with the silylated hydrophilic monomer by any convenient method, including without limitation, heat, ultraviolet light, radiation polymerization, or a combination thereof. Preferably, the polymerization is carried out in the presence of a suitable initiator present in an amount of about 0.01 to about 2.0 weight percent based on the weight of the reactants. More preferably, the polymerization is carried out with UV light using a UV polymerization initiator. The preferred UV polymerization initiator is 2-hydroxy-2-methyl- 1-phenyl-propan-1-one.
The amount of siloxane prepolymer used is about 0 to about 90 weight percent, preferably about 5 to about 70 weight percent, based on the weight of the polymerizable components. The amount of siloxane monomer used is from about 0 to about 70 weight percent, preferably from about 0 to about 40 weight percent. The amount of silylated monomer used is from about 2 to about 60 weight percent, preferably from about 15 to about 50 weight percent.
After polymerization is completed to the desired degree, the resulting polymer may be washed in an organic solvent to remove unreacted reactants. Suitable solvents include, without limitation, hexane, ethanol, isopropyl alcohol, n- and t-butyl alcohol, n-amyl alcohol, n-hexyl alcohol, as well as chlorinated solvents and the like, and mixtures thereof.
The polymer then may be desilylated by hydrolyzing to eliminate the silyl groups and to regenerate the hydroxyl group. The hydrolysis may be carried out in any suitable hydrolyzing agent. Preferably, hydrolysis is carried out by placing the lenses in a borate-buffered saline solution. Optionally, an acid or base may be used in the hydrolyzing agent to speed the hydrolysis.
One ordinarily skilled in the art will recognize that any number of a wide variety of additional components may be added to the mixture to be polymerized. Examples of such additives include, without limitation, ultra-violet absorbers, antioxidants, tints, and the like.
Any molding process may be used to form lenses from the hydrogels of the invention. For example, the siloxane prepolymer, silylated hydrophilic monomer and, optionally, the hydrophobic monomer may be blended together along with a polymerization initiator and the blend then placed into a lens mold. After polymerization is completed, the lens undergoes desilylation.
The invention will be clarified further by a consideration of the following, non-limiting examples.
214.2 g methacryloyl chloride were added dropwise to a solution of 128 g methanol, 249 g potassium carbonate, and 122.2 g ethanolamine in a three-necked flask cooling to between 5 and 15° C. in an ice bath. Addition took approximately 3 hours after which the reaction mixture was left to stir for approximately 2 days after removal of the ice bath. The reaction mixture was poured into CH2Cl2 and vacuum filtered to remove all solids, which solids were rinsed with CH2Cl2. The liquid was inhibited with 100 ppm hydroquinone monomethyl ether and the solvent removed by rotary evaporation. Residual oil was distilled under reduced pressure in a distilling flask equipped with an air ebulator, after addition of 150 ppm CuCl. 56.62 g of hydroxyethyl methacrylamide was removed as a light yellow liquid at 0.5 mm Hg and 125 to 135° C. Air was bubbled through the distilled product.
23 g trimethylsilyl chloride were added dropwise over an approximately 2 hour period to a solution of 25.3 g of the above product, 30.6 g triethylamine and 75 ml CH2Cl2 in a three-necked flask equipped with a drying tube and a magnetic stirrer. The mixture was kept at room temperature. After the addition, the reaction mixture was heated to 40° C. and stirred for approximately 5 hours. The mixture was then filtered to remove salt and the residual liquid was then rotovapped until the weight ceased to fall. The product was distilled under reduced pressure after addition of 500 ppm HQMME. 2-hydroxyethylmethacrylamide trimethylsilyl ether (“TMS-HMA”) was collected as a clear liquid at 95 to 105° C. and 0.25 mm Hg in a yield of 42 percent.
A blend was made of 20 parts of α,ω-bismethacryloxypropyl polydimethylsiloxane (5,000 average molecular wt), 45 parts of the TMS-HMA of Example 1 and 34 parts 3-methacryloxypropyltris(trimethylsiloxy) silane (“TRIS”), 1 part DAROCUR™ 1173, a photoinitiator that is 2-hydroxy-2-methyl-1-phenylproan-1-one, and 11 parts t-butanol. The blend was placed in polypropylene lens molds and irradiated for 30 min with UV light, then released in ethanol, and transferred into a borate buffered saline to produce soft, optically clear, oxygen permeable contact lenses.
|Cited Patent||Filing date||Publication date||Applicant||Title|
|US3935342||Dec 4, 1973||Jan 27, 1976||Merck Patent Gesellschaft Mit Beschrankter Haftung||Hydrophilization of non-polar surfaces|
|US4136250||Jul 20, 1977||Jan 23, 1979||Ciba-Geigy Corporation||Polysiloxane hydrogels|
|US4182822||Nov 8, 1976||Jan 8, 1980||Chang Sing Hsiung||Hydrophilic, soft and oxygen permeable copolymer composition|
|US4260725||Dec 10, 1979||Apr 7, 1981||Bausch & Lomb Incorporated||Hydrophilic contact lens made from polysiloxanes which are thermally bonded to polymerizable groups and which contain hydrophilic sidechains|
|US4261875||Jan 31, 1979||Apr 14, 1981||American Optical Corporation||Contact lenses containing hydrophilic silicone polymers|
|US4294974 *||Dec 17, 1979||Oct 13, 1981||American Optical Corporation||Hydrophilic silicone compounds and contact lenses containing polymers thereof|
|US4332922||Jul 18, 1980||Jun 1, 1982||Titmus Eurocon||Process for rendering silicone rubber contact lenses hydrophilic|
|US4419505||Jul 14, 1982||Dec 6, 1983||Paragon Optical, Inc.||Contact lens composition, article and method of manufacture|
|US4481322||Mar 30, 1983||Nov 6, 1984||Union Carbide Corporation||Novel reinforcing additive and method of reinforcing thermoplastic polymer therewith|
|US4486577||Oct 12, 1982||Dec 4, 1984||Ciba-Geigy Corporation||Strong, silicone containing polymers with high oxygen permeability|
|US4525563 *||Mar 13, 1984||Jun 25, 1985||Toyo Contact Lens Co.||Oxygen permeable soft contact lens composition|
|US4575546||Jun 22, 1984||Mar 11, 1986||Loctite Corporation||Terminal cluster vinyl silicones and acrylate cluster silicones therefrom|
|US4649184||Dec 9, 1985||Mar 10, 1987||Toyo Contact Lens Co., Ltd.||Oxygen permeable soft contact lens material|
|US5010141||Apr 18, 1990||Apr 23, 1991||Ciba-Geigy Corporation||Reactive silicone and/or fluorine containing hydrophilic prepolymers and polymers thereof|
|US5057578||Apr 10, 1990||Oct 15, 1991||E. I. Du Pont De Nemours And Company||Silicone-containing block copolymers and macromonomers|
|US5314960||Oct 9, 1991||May 24, 1994||Permeable Technologies, Inc.||Silicone-containing polymers, oxygen permeable hydrophilic contact lenses and methods for making these lenses and treating patients with visual impairment|
|US5336797||Dec 30, 1992||Aug 9, 1994||Bausch & Lomb Incorporated||Siloxane macromonomers|
|US5371147||Aug 16, 1993||Dec 6, 1994||Permeable Technologies, Inc.||Silicone-containing acrylic star polymers, block copolymers and macromonomers|
|EP0030807A1||Nov 28, 1980||Jun 24, 1981||BAUSCH & LOMB INCORPORATED||Shaped biomedical articles made of polysiloxane polymers|
|JPS6370221A||Title not available|
|Citing Patent||Filing date||Publication date||Applicant||Title|
|US7838698||Nov 23, 2010||Johnson & Johnson Vision Care, Inc.||Hydrolysis-resistant silicone compounds|
|US7897654||Mar 1, 2011||Johnson & Johnson Vision Care Inc.||Silicone prepolymer solutions|
|US8053539||Dec 12, 2006||Nov 8, 2011||Johnson & Johnson Vision Care Inc.||Siloxanyl materials for molded plastics|
|US8080622||Jun 29, 2007||Dec 20, 2011||Johnson & Johnson Vision Care, Inc.||Soluble silicone prepolymers|
|US8357818||Oct 8, 2010||Jan 22, 2013||Johnson & Johnson Vision Care, Inc.||Hydrolysis-resistant silicone compounds|
|US8399539||Nov 19, 2011||Mar 19, 2013||Johnson & Johnson Vision Care, Inc.||Soluble silicone prepolymers|
|US8569538||Dec 12, 2006||Oct 29, 2013||Johnson & Johnson Vision Care, Inc.||Acryloyl materials for molded plastics|
|US8637589||Dec 7, 2010||Jan 28, 2014||Johnson & Johnson Vision Care, Inc.||Silicone prepolymer solutions|
|US8779178||Jan 21, 2013||Jul 15, 2014||Johnson & Johnson Vision Care, Inc.||Hydrolysis-resistant silicone compounds|
|US8921449||Jan 21, 2013||Dec 30, 2014||Johnson & Johnson Vision Care Inc.||Hydrolysis-resistant silicone compounds|
|US9056878||Jun 10, 2014||Jun 16, 2015||Johnson & Johnson Vision Care, Inc.||Hydrolysis-resistant silicone compounds|
|US9056880||Nov 7, 2012||Jun 16, 2015||Johnson & Johnson Vision Care, Inc.||Process for producing hydrolysis-resistant silicone compounds|
|US20080004383 *||Dec 12, 2006||Jan 3, 2008||Masataka Nakamura||Acryloyl materials for molded plastics|
|US20080004401 *||Dec 12, 2006||Jan 3, 2008||Masataka Nakamura||Siloxanyl materials for molded plastics|
|US20080081850 *||Nov 20, 2006||Apr 3, 2008||Kazuhiko Fujisawa||Process for producing hydrolysis-resistant silicone compounds|
|US20080119627 *||Mar 2, 2007||May 22, 2008||Masataka Nakamura||Methods for purifying siloxanyl monomers|
|US20090005528 *||Jun 29, 2007||Jan 1, 2009||Kazuhiko Fujisawa||Soluble silicone prepolymers|
|US20090171026 *||Apr 1, 2008||Jul 2, 2009||Kazuhiko Fujisawa||Silicone prepolymer solutions|
|US20110028673 *||Feb 3, 2011||Kazuhiko Fujisawa||Hydrolysis-resistant silicone compounds|
|US20110077322 *||Mar 31, 2011||Kazuhiko Fujisawa||Silicone Prepolymer Solutions|
|U.S. Classification||526/279, 522/99, 525/383|
|International Classification||C08F30/08, C08L83/04, C08F230/08, C08F290/06, C08F8/12, C08F220/54, C08J3/02|
|European Classification||C08F8/12, C08F230/08|
|Aug 10, 2007||FPAY||Fee payment|
Year of fee payment: 8
|Jul 27, 2011||FPAY||Fee payment|
Year of fee payment: 12